Similar Articles
421 Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
422 Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma
423 Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma
424 Complete resection of large-cell neuroendocrine and hepatocellular carcinoma of the liver: A case report
425 Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching
426 RASSF1A methylation as a biomarker for detection of colorectal cancer and hepatocellular carcinoma
427 Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures
428 Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study
429 Prognostic role of expression of angiogenesis markers in hepatocellular carcinoma: A bioinformatics analysis
430 Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA